Prochlorperazine Mesilate 12.5mg/ml Solution for Injection Malta - English - Medicines Authority

prochlorperazine mesilate 12.5mg/ml solution for injection

mercury pharma international limited 4045 kingswood road, city west business park, co, dublin, ireland - prochlorperazine mesilate - solution for injection - prochlorperazine mesilate 12.5 mg/ml - psycholeptics

Levomepromazine hydrochloride 25mg/ml Solution for Injection Malta - English - Medicines Authority

levomepromazine hydrochloride 25mg/ml solution for injection

pinewood laboratories limited ballymacarbry, clonmel, co. tipperary, ireland - levomepromazine hydrochloride - solution for injection - levomepromazine hydrochloride 25 mg/ml - psycholeptics

Ropivacaine Kabi 5 mg/ml solution for injection - 10ml Malta - English - Medicines Authority

ropivacaine kabi 5 mg/ml solution for injection - 10ml

fresenius kabi italia s.r.l via camagre 41, 37063 isola della scala (vr) , italy - ropivacaine hydrochloride - solution for injection - ropivacaine hydrochloride 5 mg/ml - anesthetics

LIDOCAINE-BAXTER lidocaine (lignocaine) hydrochloride (as monohydrate) 50 mg/5 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

lidocaine-baxter lidocaine (lignocaine) hydrochloride (as monohydrate) 50 mg/5 ml solution for injection ampoule

baxter healthcare pty ltd - lidocaine hydrochloride monohydrate, quantity: 53.3 mg (equivalent: lidocaine hydrochloride, qty 50 mg) - injection, solution - excipient ingredients: hydrochloric acid; water for injections; sodium chloride; sodium hydroxide - for production of local or regional anaesthesia by nerve block, infiltration injection, caudal or other epidural blocks. treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication, or following resuscitation from cardiac arrest.

LIDOCAINE-BAXTER lidocaine (lignocaine) hydrochloride (as monohydrate) 200 mg/20 mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

lidocaine-baxter lidocaine (lignocaine) hydrochloride (as monohydrate) 200 mg/20 ml solution for injection vial

baxter healthcare pty ltd - lidocaine hydrochloride monohydrate, quantity: 213.2 mg (equivalent: lidocaine hydrochloride, qty 200 mg) - injection, solution - excipient ingredients: water for injections; sodium chloride; hydrochloric acid; sodium hydroxide - for production of local or regional anaesthesia by nerve block, infiltration injection, caudal or other epidural blocks. treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication, or following resuscitation from cardiac arrest.

LIDOCAINE-BAXTER lidocaine (lignocaine) hydrochloride (as monohydrate) 40 mg/2 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

lidocaine-baxter lidocaine (lignocaine) hydrochloride (as monohydrate) 40 mg/2 ml solution for injection ampoule

baxter healthcare pty ltd - lidocaine hydrochloride monohydrate, quantity: 42.66 mg (equivalent: lidocaine hydrochloride, qty 40 mg) - injection, solution - excipient ingredients: sodium hydroxide; water for injections; sodium chloride; hydrochloric acid - for production of local or regional anaesthesia by nerve block, infiltration injection, caudal or other epidural blocks. treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication, or following resuscitation from cardiac arrest.

LIDOCAINE-BAXTER lidocaine (lignocaine) hydrochloride (as monohydrate) 20 mg/2 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

lidocaine-baxter lidocaine (lignocaine) hydrochloride (as monohydrate) 20 mg/2 ml solution for injection ampoule

baxter healthcare pty ltd - lidocaine hydrochloride monohydrate, quantity: 21.32 mg (equivalent: lidocaine hydrochloride, qty 20 mg) - injection, solution - excipient ingredients: sodium hydroxide; sodium chloride; hydrochloric acid; water for injections - for production of local or regional anaesthesia by nerve block, infiltration injection, caudal or other epidural blocks. treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication, or following resuscitation from cardiac arrest.

LIDOCAINE-BAXTER lidocaine (lignocaine) hydrochloride (as monohydrate) 400 mg/20 mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

lidocaine-baxter lidocaine (lignocaine) hydrochloride (as monohydrate) 400 mg/20 ml solution for injection vial

baxter healthcare pty ltd - lidocaine hydrochloride monohydrate, quantity: 426.6 mg (equivalent: lidocaine hydrochloride, qty 400 mg) - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections; sodium hydroxide - for production of local or regional anaesthesia by nerve block, infiltration injection, caudal or other epidural blocks. treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication, or following resuscitation from cardiac arrest.

LIDOCAINE-BAXTER lidocaine (lignocaine) hydrochloride (as monohydrate) 100 mg/5 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

lidocaine-baxter lidocaine (lignocaine) hydrochloride (as monohydrate) 100 mg/5 ml solution for injection ampoule

baxter healthcare pty ltd - lidocaine hydrochloride monohydrate, quantity: 106.65 mg (equivalent: lidocaine hydrochloride, qty 100 mg) - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; hydrochloric acid; water for injections - for production of local or regional anaesthesia by nerve block, infiltration injection, caudal or other epidural blocks. treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication, or following resuscitation from cardiac arrest.

Ropivacaine Kabi 7.5 mg/ml solution for injection - 10ml Malta - English - Medicines Authority

ropivacaine kabi 7.5 mg/ml solution for injection - 10ml

fresenius kabi italia s.r.l via camagre 41, 37063 isola della scala (vr) , italy - ropivacaine hydrochloride - solution for injection - ropivacaine hydrochloride 7.5 mg/ml - anesthetics